PATH | VRL
Menu

Effectiveness of Pentavalent and Monovalent Rotavirus Vaccines in Concurrent Use Among US Children <5 Years of Age, 2009–2011

This article, published in Clinical Infectious Diseases, summarizes a study that assessed vaccine effectiveness of RotaTeq (RV5; 3 doses) and Rotarix (RV1; 2 doses) at reducing rotavirus acute gastroenteritis inpatient and emergency department (ED) visits in US children. Results showed that RV5 and RV1 were 84 percent and 70 percent effective, respectively, against rotavirus-associated ED visits and hospitalizations combined. Therefore, both RV5 and RV1 significantly protected against medically attended rotavirus gastroenteritis in this assessment. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)

Author: Payne DC, Boom JA, Staat MA, et al.

Published: 2013

» Visit web page (English)

(Located at cid.oxfordjournals.org)

Citation: Payne DC, Boom JA, Staat MA, et al. Effectiveness of Pentavalent and Monovalent Rotavirus Vaccines in Concurrent Use Among US Children <5 Years of Age, 2009–2011. Clinical Infectious Diseases. 2013;57(1):13-20.

Resource types: Peer-reviewed journal

Diseases/vaccines: Rotavirus

Topics: Vaccine safety and performance, Disease/vaccine specific information

Regions: North America and Europe